BioSpace News Archive

Government Stimulus to Medical Innovations Driving the Medical Holography Market Growth at 34% CAGR

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global medical holography market is anticipated to reach US$ 3.5 billion by the end of 2026 in comparison to US$ 447.8 million valuation in 2019.

October 12, 2021
·
7 min read
Over 1/3rd of High Performance Liquid Chromatography Demand to Concentrate in Europe

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global high performance liquid chromatography market is estimated to grow at a healthy CAGR of 5.4% during the forecast period from 2020 to 2026.

October 12, 2021
·
8 min read
Angelman Syndrome Treatment Market: Rising demand for effective treatment solutions for angelman syndrome to drive the market

Angelman syndrome can be defined as a rare and complex genetic condition that predominantly affects nervous systems.

October 12, 2021
·
5 min read
ACL Reconstruction Market: Growth in the Prevalence of Sport-related Injuries across Major Parts of the Globe to Drive the Market

Growth in the prevalence of sport-related injuries across major parts of the globe is anticipated to drive demand opportunities in the global ACL reconstruction market during the forecast period of 2021 to 2031.

October 12, 2021
·
5 min read
OSE Immunotherapeutics to Host Today a Virtual “Immuno-Oncology R&D Day”

OSE Immunotherapeutics will host a virtual R&D Day on Tuesday, October 12th, 2021 at 4:00 p.m. CEST/ 10:00 a.m. EDT.

October 12, 2021
·
6 min read
Essity launches digital solution for wound management

Hygiene and health company Essity is launching Cutimed Wound Navigator, a new digital solution for wound assessment.

October 12, 2021
·
2 min read
Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR

Helsinn Group and Fosun Pharmaceutical A.G. announced the signing of exclusive license and distribution agreements effective from October 1st 2021 in the territory of Mainland China for Aloxi®, Akynzeo® and anamorelin.

October 12, 2021
·
7 min read
Business

Salipro Biotech enters into a collaboration and license agreement with AbCellera for access to the Salipro® Platform for antibody discovery against GPCRs, ion channels, and transporters

Swedish biotech company Salipro Biotech AB announced that it has entered into a collaboration and licensing agreement with AbCellera for access to its proprietary Salipro® Platform, which stabilizes challenging G protein coupled receptor, ion channel, and transporter antigens.

October 12, 2021
·
2 min read
Business

Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International

Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, announced that Andreas S. Tsukada has joined the Company as Senior Vice President, President of Japanese Operations and Head of International.

October 12, 2021
·
3 min read
Biotech Beach

Evofem Biosciences Announces $10 Million Registered Direct Offering of Series B Preferred Stock

Evofem Biosciences, Inc. announced that it has entered into a definitive agreement with Keystone Capital Partners providing for the issuance and sale of an aggregate of 10,000 shares of Series B Convertible Stock in a registered direct offering for a purchase price of $1,000.00 per share.

October 12, 2021
·
4 min read